United Therapeutics CorporationUTHRNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank36
3Y CAGR-52.1%
5Y CAGR-54.2%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-52.1%/yr
Annual compound
5Y CAGR
-54.2%/yr
Consistent
Percentile
P36
Within normal range
vs 5Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 8.39% |
| 2024 | 16.21% |
| 2023 | 20.95% |
| 2022 | 76.24% |
| 2021 | -6.35% |
| 2020 | 416.42% |
| 2019 | -123.29% |
| 2018 | -1.17% |
| 2017 | -23.25% |
| 2016 | 51.89% |